Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #163644 on Biotech Values
dav1234
07/08/13 5:58 PM
#163645 RE: biomaven0 #163644
$AMRN Vascepa Rx growth (month over month) since launch: 125%, 70%, 31%, 14%— Adam Feuerstein ✡️ (@adamfeuerstein) July 8, 2013
$AMRN Vascepa Rx growth (month over month) since launch: 125%, 70%, 31%, 14%
Subscribe to Ad free and enjoy an ad-free experience
Try Now
Keep the Ads